Minimum Proceeds. There shall be issued at the Closing, Series B Shares with an aggregate purchase price of at least $850,000.
Appears in 2 contracts
Sources: Series B Preferred Stock Purchase Agreement (Genomic Solutions Inc), Series B Preferred Stock Purchase Agreement (Genomic Solutions Inc)